Acadia Pharma GAAP EPS of $0.20 beats by $0.06, revenue of $250.4M beats by $1.56M

  • Acadia Pharma press release (NASDAQ:ACAD): Q3 GAAP EPS of $0.20 beats by $0.06.
  • Revenue of $250.4M (+18.3% Y/Y) beats by $1.56M.

Leave a Reply

Your email address will not be published. Required fields are marked *